Clinical Trial Update: A Multicenter, Randomized, Placebo-Controlled, Double-Blind Study of SUN13834 in Adult Subjects With Atopic Dermatitis [Phase 2]

View source ↗

Summary

A Phase 2 multicenter randomized double-blind study of SUN13834 in adults with atopic dermatitis has completed, with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Atopic Dermatitis

Drugs mentioned

• SUN13834

Snippet

Sponsor: Daiichi Sankyo | Conditions: Atopic Dermatitis | Phase 2 | Status: COMPLETED | Results posted: 2021-04-21